Two Immune Cell Armies in One Infusion: Combination NK and T Cell Therapy Shows Promise in Hard-to-Treat Tumors
A phase 1 trial found that an autologous combination of natural killer cells and tumor-primed T lymphocytes was safe and ...
A phase 1 trial found that an autologous combination of natural killer cells and tumor-primed T lymphocytes was safe and ...
A comprehensive proteomic study of platelet-rich plasma from elderly donors identifies 1,378 proteins, including 324 unique to PRP, supporting autologous ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine